Medicament for treating anaphylactoid purpura

Abstract

The invention relates to a medicament for treating anaphylactoid purpura, which is characterized by being prepared from the following raw materials in part by weight: 5 to 10 parts of weeping forsythia, 10 to 30 parts of fineleaf schizonepeta herb, 10 to 30 parts of Sinkiang arnebia root, 10 to 30 parts of red paeony root, 5 to 10 parts of garden burnet root, 5 to 15 parts of liquoric root, 10 to 30 parts of hairyvein agrimonia herb and 5 to 20 parts of safflower. The invention has the advantage that the medicament is prepared from common Chinese herbal medicines on the basis of the conventional theory of traditional Chinese medicine, and has the effects of clearing heat and detoxicating, dispelling wind and relieving exterior syndrome and cooling blood and promoting blood circulation; and in a formula, weeping forsythia is used for clearing heat and detoxicating, fineleaf schizonepeta herb is used for dispelling wind and relieving exterior syndrome, Sinkiang arnebia root is used for clearing heat and cooling blood, garden burnet root is used for cooling blood and stopping bleeding, hairyvein agrimonia herb is used for astringing to arrest bleeding, safflower is used for promoting blood circulation and dispelling stasis, red paeony root is used for stopping bleeding and dispelling stasis, and liquoric root is used for harmonizing the medicaments. The medicament has the good effects of purpura caused by injury of blood collaterals by heat, obstruction of collaterals by blood stasis, exogenous wind-heat evil and internal invading into blood vessels, can reduce the recurrence rate effectively and does not have toxic or side effect.

Description

Technical field: [0001] The invention relates to a medicine for treating allergic purpura, which belongs to the field of traditional Chinese medicine preparations. Background technique: [0002] Henoch-Schonlein purpura is a kind of allergic vasculitis that invades the capillaries and arterioles of the skin or other organs. At present, there are not many drugs for the treatment of Henoch-Schonlein purpura. Western medicine can only use immunosuppressants, hormones and other drugs To control the disease, long-term large-scale use of such drugs is likely to cause more adverse reactions, easy recurrence, and difficulty in stopping the drug. However, traditional Chinese medicine or integrated traditional Chinese and Western medicine have better curative effects on the treatment of such diseases. Invention content: [0003] The purpose of the present invention is to provide a new medicine for treating allergic purpura, so as to better meet the needs of medical treatment. [00...

AI Technical Summary

Problems solved by technology

[0002] Henoch-Schonlein purpura is a kind of allergic vasculitis that invades the capillaries and arterioles of the skin or other organs. At present, there are not many drugs for the treatment of Henoch-Schonlein purpura. Western medicine can only use immunosuppressants, hormones and other drugs To control the disease, long-term and large-scale use of such drugs can easily cause more adverse reactions, easy recurrence, and difficulty in stopping the drug. However, traditional Chinese medicine or the combination of traditional Chinese and Western medicine has a better effect on the treatment of such diseases